Revenue | $100 - $500 million See Exact Annual Revenue |
---|---|
Employees | 100 - 500Exact Company Size |
Primary Industry | 325411 Medicinal & Botanical Manufacturing |
Additional NAICS Codes | 325412 Pharmaceutical Preparation Manufacturing 5417 Scientific Research & Development Services |
Address | 3200 Walnut St Boulder, CO 80301 |
Array Biopharma | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
---|---|---|---|
2023 | $100 - $500 million Details in Premium Report | ||
2022 | |||
2021 | |||
2020 | |||
2019 |
1-Year Growth Rate: 3-Year Growth Rate (CAGR): | ![]() |
Array Biopharma P&L | $ Millions |
---|---|
Revenue (Sales) | ![]() |
Cost of Goods Sold | |
Gross Profit | |
Operating Expenses | |
Advertising | |
Salaries and wages | |
Other Operating Expenses | |
Total Operating Expenses | |
Operating Income | |
EBITDA | |
EBIT (Earnings Before Interest and Taxes) | |
Net Profit | |
Trademark | Date |
---|---|
YARRA THERAPEUTICS Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer and tumors; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma | 03/08/2018 |
BRAFTOVI ENCORAFENIB CAPSULES [ Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use;] Pharmaceutical products for the [ prevention and ] treatment of cancer [ and tumors; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma ] | 01/16/2018 |
ARRAY | ACTS ACCESS COVERAGE | TREATMENT SUPPORT Printed publications, namely, brochures, booklets and teaching materials regarding the use of pharmaceuticals | 04/13/2017 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
XYMOGEN | Orlando, FL | 100 |
AVANTI NUTRITIONAL LABORATORIES | Miami Lakes, FL | 37 |
NUTRITION FORMULATORS | Miramar, FL | 36 |
RTPR | Cabot, AR | 33 |
INTEGRATED BOTANICS | Fort Worth, TX | 29 |
COSMAX NBT USA | Garland, TX | 29 |
CJB INDUSTRIES | Valdosta, GA | 28 |
ALTERNATIVE LABORATORIES | Naples, FL | 28 |
S&B PHARMA | Azusa, CA | 28 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
CORDEN PHARMA COLORADO | Boulder, CO | 100 |
ARRAY BIOPHARMA | Boulder, CO | 38 |
ENVEDA THERAPEUTICS | Boulder, CO | 35 |
DROPWORKS | Boulder, CO | 9 |
MATY'S HEALTHY PRODUCTS | Boulder, CO | 3 |
BRICKELL BIOTECH | Boulder, CO | 2 |
Company | Revenue ($ MM) |
---|---|
![]() |